Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Tempo Scan Pacific Tbk is a leading Indonesian pharmaceutical, consumer health, and cosmetics company founded in 1970. The company operates through three main business segments: Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. Tempo Scan manufactures and markets well-known over-the-counter (OTC) brands such as Bodrex and Hemaviton, alongside a portfolio of prescription medicines, vitamins, and nutritional products. With 16 manufacturing plants and an extensive nationwide distribution network, the company serves both domestic and international markets in Southeast Asia and Africa. In July 2026, Tempo Scan established a strategic joint venture with Sino Biopharmaceutical (CTTQ) to accelerate the registration, clinical development, and commercialization of innovative oncology and specialty drugs in Indonesia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tempo Scan Pacific.